![Intratumoral immune triads are required for effective immunotherapy](https://oncodaily.com/pub/uploads/2024/06/Optic-Pathway-Gliom.png)
Photo taken from NCI/LinkedIn
Jun 26, 2024, 02:10
Intratumoral immune triads are required for effective immunotherapy
NCI Division of Cancer Biology shared on X:
“Using preclinical models in an NCI-funded study, Gabriel Espinosa Carrasco, The SchietiLab, et al. found that intratumoral immune triads (with a dendritic cell, CD4 T cell, and CD8 T cell) are required for effective immunotherapy.”
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors
Authors: Gabriel Espinosa-Carrasco, Edison Chiu, Aurora Scrivo, Paul Zumbo, Asim Dave, Doron Betel, Sung Wook Kang, Hee-Jin Jang, Matthew D. Hellmann, Bryan M. Burt, Hyun-Sung Lee, Andrea Schietinger
Source: NCI Division of Cancer Biology/X